Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma
In patients with relapsed/refractory multiple myeloma (RRMM) who received at least one prior line of therapy (LOT), treatment with belantamab mafodotin (belamaf) plus pomalidomide and dexamethasone (BPD) results in statistically significant and clinically meaningful progressive-free survival (PFS) compared with pomalidomide plus bortezomib and dexamethasone (PVD), as shown in the DREAMM-8 study.

New risk factor identified for sudden infant death: Maternal obesity
Infants born to mothers with prepregnancy obesity are at risk of sudden unexpected infant death (SUID), with the risk increase commensurate with maternal BMI, according to a large US nationwide cohort study.

Fenofibrate staves off vision loss in diabetes
The antilipidemic drug fenofibrate averts or delays diabetic retinopathy (DR) in diabetes patients with early retinal changes in the LENS trial, potentially paving the way for the least invasive route of drug delivery in this population.





